Relay Therapeutics Inc (RLAY)

SG&A Expenses

$51.18M

TTM · Period ending: · USD

RLAY logo

RLAY SG&A Expenses

Latest reported$51.18M
RLAY TTM SG&A Expenses ($13.65M → $51.18M)
High-resolution chart · PNG

RLAY sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Relay Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
51,183,000
50,244,000
57,956,000
65,545,000
72,793,000
79,180,000
80,240,000
80,085,000
78,820,000
78,801,000
78,581,000
77,905,000
75,494,000
72,839,000
69,328,000
65,081,000
64,508,000
61,465,000
58,132,000
57,997,000
54,727,000
46,358,000
38,381,000
26,468,000
17,889,000
15,344,000
13,653,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.